Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Liebes

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
In Vivo (Athens, Greece)|November 1, 1993
Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugsJ Bezault, C Walsh, L Tarcsay, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Increased ascorbic acid content in chronic lymphocytic leukemia B lymphocytesL Liebes, R Krigel, S Kuo, et al.
Annals of the New York Academy of Sciences|December 13, 1996
9-Aminocamptothecin and beyond. Preclinical and clinical studiesM Potmesil, S G Arbuck, C H Takimoto, et al.
Biochemistry|October 21, 1975
Electrophoretic mobilities of RNA tumor viruses. Studies by Doppler-shifted light scattering spectroscopyL Rimai, I Salmeen, D Hart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): a phase I study with pharmacologyH Hochster, M Green, L Liebes, et al.
Cancer Research|August 1, 1993
Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancerJ A Sparano, S Wadler, L Liebes, et al.
Cancer|February 1, 1994
Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary resultsE L Kramer, M E Noz, L Liebes, et al.
Cancer Research|April 18, 2001
Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenograftsB Ng, E Kramer, L Liebes, et al.
Photochemistry and Photobiology|February 25, 2000
Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericinA M Prince, D Pascual, D Meruelo, et al.
Cancer Chemotherapy and Pharmacology|September 20, 2013
A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicityB Kobrinsky, S O Joseph, F Muggia, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
In Vivo (Athens, Greece)|November 1, 1993
Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugsJ Bezault, C Walsh, L Tarcsay, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Increased ascorbic acid content in chronic lymphocytic leukemia B lymphocytesL Liebes, R Krigel, S Kuo, et al.
Annals of the New York Academy of Sciences|December 13, 1996
9-Aminocamptothecin and beyond. Preclinical and clinical studiesM Potmesil, S G Arbuck, C H Takimoto, et al.
Biochemistry|October 21, 1975
Electrophoretic mobilities of RNA tumor viruses. Studies by Doppler-shifted light scattering spectroscopyL Rimai, I Salmeen, D Hart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): a phase I study with pharmacologyH Hochster, M Green, L Liebes, et al.
Cancer Research|August 1, 1993
Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancerJ A Sparano, S Wadler, L Liebes, et al.
Cancer|February 1, 1994
Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary resultsE L Kramer, M E Noz, L Liebes, et al.
Cancer Research|April 18, 2001
Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenograftsB Ng, E Kramer, L Liebes, et al.
Photochemistry and Photobiology|February 25, 2000
Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericinA M Prince, D Pascual, D Meruelo, et al.
Cancer Chemotherapy and Pharmacology|September 20, 2013
A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicityB Kobrinsky, S O Joseph, F Muggia, et al.
Pageof 5